Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pfizer, J&J sign on to uninsured plan

Executive Summary

Pfizer and Johnson & Johnson are among the proponents of a multi-stakeholder agreement to expand health coverage to the uninsured; the broad-brush proposal, unveiled Jan. 18 by the Health Coverage Coalition for the Uninsured, advocates a two-phase process, starting with a "kids first" initiative to expand the State Children's Health Insurance Program. The second phase would expand Medicaid availability to adults and offer new tax credit incentives for employer-sponsored coverage. Two years in development, the policy statement "allows the new Congress to begin its work on health coverage for a proposal that already has the agreement of diverse advocates," the coalition states. Members also include America's Health Insurance Plans, UnitedHealth Group, AARP, the American Medical Association, and the U.S. Chamber of Commerce...

Latest Headlines
See All
UsernamePublicRestriction

Register

PS047954

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel